Common viral vectors and the application of Nanocoulter I in drug delivery

2021-12-24

Application of “Single Particles” in Liposomes, Viruses and Other Bio-nano Drugs

2021-11-12

Nanocoulter I [drug carrier quality control, nano particle detection] - to meet your scientific research needs

2021-10-25

Nanocoulter Ⅰ Nanocoulter Single Particle Analyzer

2021-09-17

How to View the Phenomenon of Nanoparticle Agglomeration-Resun Ultra-sensitive Particle Size Measurement

2021-09-06

The 11th Annual Academic Conference and Cross-strait Particle Technology Seminar

2020-10-26

The 11th Annual Academic Conference and Cross-strait Particle Technology Seminar of Chinese Society of Particuology will be held in Xiamen, Fujian Province from October 23 to 25, 2020 (arrive on October 23). The conference was co-hosted by Chinese Society of Particuology, Datong University (Taipei) and National Taipei University of Technology, and co-organized by the Professional Committee on Biological Particles of the Chinese Society of Particuology, Jimei University, State Key Laboratory of High-efficiency Utilization of Coal and Green Chemical Engineering, and Qingdao University of Science & Technology.

Fudan University Found that Exosome miR-150 is a Potential Biomarker of Myasthenia Gravis Disease

2020-11-30

Myasthenia gravis (MG) is an autoimmune disease caused by the dysfunction of nerve-muscle junction transmission. The clinical manifestations are mainly partial or systemic skeletal muscle weakness and fatigue. The prevalence rate is (77~150)/1 million, and the annual incidence rate is (4~11)/1 million. Recently, research from Zhao Chongbo and Luo Sushan’s team in Huashan Hospital of Fudan University found out that low-dose rituximab (RTX) is effective in the treatment of patients with acetylcholine receptor (AChR) positive refractory myasthenia gravis. Meanwhile, RTX can reduce the level of serum exosome miR-150. The results suggest that exosome miR-150 is a potential biomarker for myasthenia gravis disease.